Ensysce Biosciences, Inc. ENSC Q4 2025 Annual earnings

FAQ

When did Ensysce Biosciences, Inc. report Q4 2025 earnings?

Ensysce Biosciences, Inc. (ENSC) reported Q4 2025 earnings on March 30, 2026 after market close.

What were Ensysce Biosciences, Inc.'s Q4 2025 revenue and EPS?

Ensysce Biosciences, Inc. reported revenue of $1.9M and eps of $-0.75 for Q4 2025.

Did Ensysce Biosciences, Inc. beat estimates in Q4 2025?

Revenue beat the consensus estimate of $503.0K by $1.4M. EPS beat the consensus estimate of $-1.26 by $0.51.

How did Ensysce Biosciences, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 45.7% from $1.3M a year earlier and eps grew 74.1% from $-2.90.

Where can I find Ensysce Biosciences, Inc.'s Q4 2025 SEC filings?

You can read the 8-K earnings release (0001493152-26-013314) and the 10-K periodic report (0001493152-26-013633) directly on SEC EDGAR. The filing index links above go to sec.gov.